96 related articles for article (PubMed ID: 34971320)
1. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
He N; Yan Y; Su S; Ge Q; Zhai S
Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
Alshamsi F; Belley-Cote E; Cook D; Almenawer SA; Alqahtani Z; Perri D; Thabane L; Al-Omari A; Lewis K; Guyatt G; Alhazzani W
Crit Care; 2016 May; 20(1):120. PubMed ID: 27142116
[TBL] [Abstract][Full Text] [Related]
3. Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study.
Al Sulaiman K; Al Aamer K; Al Harthi A; Jaser S; Al Anazi A; Al Subaie S; Vishwakarma R
Pharmacol Res Perspect; 2020 Aug; 8(4):e00624. PubMed ID: 32702782
[TBL] [Abstract][Full Text] [Related]
4. The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
Fan W; Liu H; Shen Y; Hong K
Cardiovasc Drugs Ther; 2024 Jun; 38(3):517-525. PubMed ID: 36625987
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis.
Tricco AC; Alateeq A; Tashkandi M; Mamdani M; Al-Omran M; Straus SE
Open Med; 2012; 6(3):e109-17. PubMed ID: 23687524
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors for gastrointestinal bleeding prophylaxis in critically ill patients: A systematic review protocol.
Wang Y; Heels-Ansdell D; Ge L; Parpia S; Ibrahim Q; Cook D; Deane A; Lauzier F; Hammond N; Møller MH; Krag M; Perner A; Guyatt GH
Acta Anaesthesiol Scand; 2024 Apr; ():. PubMed ID: 38581102
[TBL] [Abstract][Full Text] [Related]
7. Clinically Significant Gastrointestinal Bleeding Using Proton Pump Inhibitors or Histamine Type-2 Receptor Antagonists in Patients Intubated for over 48 Hours: A Systematic Review and Meta-Analysis.
Khokher W; Kesireddy N; Iftikhar S; Beran A; Abuhelwa Z; Malhas SE; Saif T; Rashid R; Ali H; Malik A; Assaly R
Am J Ther; 2024 Jan-Feb 01; 31(1):e62-e66. PubMed ID: 35703440
[No Abstract] [Full Text] [Related]
8. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.
Madej J; Atanassova T; McGuire S; Cohen B; Weidner M; Zhang Y; Horton DB
Pediatr Allergy Immunol; 2023 Nov; 34(11):e14042. PubMed ID: 38010007
[TBL] [Abstract][Full Text] [Related]
9. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
Arinze JT; de Ridder MAJ; Vojinovic D; van Ballegooijen H; Markov E; Duarte-Salles T; Rijnbeek P; Verhamme KMC
Drug Saf; 2023 Dec; 46(12):1353-1362. PubMed ID: 37907775
[TBL] [Abstract][Full Text] [Related]
10. Stress Ulcer Prophylaxis Versus Placebo-A Blinded Pilot Randomized Controlled Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart Disease.
Mills KI; Albert BD; Bechard LJ; Chu S; Duggan CP; Kaza A; Rakoff-Nahoum S; Sleeper LA; Newburger JW; Priebe GP; Mehta NM
Pediatr Crit Care Med; 2024 Feb; 25(2):118-127. PubMed ID: 38240536
[TBL] [Abstract][Full Text] [Related]
11. Prediction and prevention of upper gastrointestinal bleeding after cardiac surgery: a case control study.
Bhat M; Larocque M; Amorim M; Herba K; Martel M; De Varennes B; Barkun A
Can J Gastroenterol; 2012 Jun; 26(6):340-4. PubMed ID: 22720275
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases.
Mitsuboshi S; Hamano H; Kuniki Y; Niimura T; Chuma M; Ushio S; Lin TJ; Matsumoto J; Takeda T; Kajizono M; Zamami Y; Ishizawa K
Ann Pharmacother; 2023 Nov; 57(11):1255-1263. PubMed ID: 36847276
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic proton pump inhibitors in femoral neck fracture patients - A life - and cost-saving intervention.
Singh R; Trickett R; Meyer C; Lewthwaite S; Ford D
Ann R Coll Surg Engl; 2016 Jul; 98(6):371-5. PubMed ID: 27055405
[TBL] [Abstract][Full Text] [Related]
14. Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients Impacts Morbidity and Mortality: A Propensity Score-Matched Cohort Study.
Palmowski L; von Busch A; Unterberg M; Bergmann L; Schmitz S; Schlüter A; Peters J; Adamzik M; Rahmel T
Crit Care Med; 2024 Feb; 52(2):190-199. PubMed ID: 38240505
[TBL] [Abstract][Full Text] [Related]
15. Effect of Antacids on the Survival of Patients With Metastatic Urothelial Carcinoma Treated With Pembrolizumab.
Sekito T; Bekku K; Katayama S; Watanabe T; Tsuboi I; Yoshinaga K; Maruyama Y; Yamanoi T; Kawada T; Tominaga Y; Sadahira T; Iwata T; Nishimura S; Kusumi N; Edamura K; Kobayashi T; Kurose K; Ichikawa T; Miyaji Y; Wada K; Kobayashi Y; Araki M
Clin Genitourin Cancer; 2024 Apr; 22(4):102097. PubMed ID: 38763123
[TBL] [Abstract][Full Text] [Related]
16. Association between use of antacid medications (proton pump inhibitors and histamine-2 receptor antagonists) and the incidence of lung cancer: A population-based cohort analysis.
Go S; Lee DY; Choi WI; Jeong J
Medicine (Baltimore); 2022 Sep; 101(36):e30399. PubMed ID: 36086741
[TBL] [Abstract][Full Text] [Related]
17. Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort Study.
Pan JM; Guo Y; Jiang FF; Xu R; Zhang X; Cai WK; Yin SJ; Wang P; Huang YH; Zhang XS; Li YH; Cai L; He GH
J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38659369
[TBL] [Abstract][Full Text] [Related]
18. Association between proton pump inhibitor use and neurological or psychiatric disorders: a systematic review protocol.
Lin J; Liao P; Qian J; Qin Y; Xu D; He WQ; Liang X; Qin X
JBI Evid Synth; 2023 Nov; 21(11):2239-2246. PubMed ID: 37555780
[TBL] [Abstract][Full Text] [Related]
19. Pantoprazole and Vonoprazan Performed Well in Preventing Peptic Ulcer Recurrence in Low-Dose Aspirin Users.
An H; Chen J; Li S; Chen A
Dig Dis Sci; 2024 Mar; 69(3):670-682. PubMed ID: 38252210
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis.
Toubasi AA; AbuAnzeh RB; Khraisat BR; Al-Sayegh TN; AlRyalat SA
Arch Med Res; 2021 Aug; 52(6):656-659. PubMed ID: 33814207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
